Software provides risk management in pharmaceutical industry.
Share:
Press Release Summary:
Argus Perceptive(TM), combined with Argus Insight(TM), builds on safety knowledge base to provide proactive approach to pharmacovigilance. Software features analytical engines enabling real-time, auditable means for automated signal detection, analysis, documentation, and communication. It integrates with various industry analytical and visualization engines to help pharmaceutical, biotech, and medical device companies with drug safety and compliance regulations.
Original Press Release:
Relsys International Launches Argus Perceptive(TM) Establishing the Benchmark for Systematic Pharmacovigilance and Risk Management
IRVINE, Calif., Feb. 28 // -- Relsys International, the leading provider of Safety and Risk Management solutions, announces the availability of Argus Perceptive(TM), a visionary pharmacovigilance tool that is changing the way the bio-pharma industry manages risk.
Argus Perceptive(TM) from Relsys, when combined with Argus Insight(TM), builds on a comprehensive safety knowledge base to provide a proactive approach to pharmacovigilance. Powerful analytical engines enable a real-time, auditable means for automated signal detection, analysis and documentation, and communication, to provide complete risk management support. Argus Perceptive(TM) integrates with the industry's leading analytical and visualization engines such as DrugLogic's Qscan and Relsys' Argus Insight(TM).
Dave Bajaj, President and CEO of Relsys International Inc. stated, "It brings me great pleasure to announce the availability of Argus Perceptive(TM). In our twentieth anniversary year, Relsys remains committed to providing cutting edge and innovative solutions that address our customers' needs." Sanket Agrawal, Relsys' Chief Strategy Officer, added, "It is no longer enough to passively monitor adverse events. Argus Perceptive(TM) enables the most compelling and holistic approach to proactive pharmacovigilance and risk management today, and forms the platform for further innovations. We are proud to accelerate our lead in the safety arena."
Relsys will be showcasing Argus Perceptive(TM) and other innovations at the annual DIA EuroMeeting in Vienna, Austria.
About Relsys International
Relsys International provides a complete systems solution for pharmacovigilance and risk management that help pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's best selling adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit relsys.net, or call +1 949-453-1715 (in Europe call +44 20 8849 8058).
Source: Relsys International
CONTACT: Relsys International, +1-949-453-1715, or Europe,
+44 20 8849 8058
Web site: http://relsys.net/
